Isaac Alex Bowman

4PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)General practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 03, 2025
IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial Carcinoma.

David H Aggen, Meredith McKean, Jean H Hoffman-Censits

|Sep 08, 2022
ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma.

Aditi Mulgaonkar, Roy Elias, Layton Woolford

|Aug 18, 2021
Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trial.

Caitlin C Murphy, Hannah M Fullington, David E Gerber

|Aug 11, 2020
Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital.

Nathan Chertack, Rashed A Ghandour, Nirmish Singla

Pageof 1

Frequent Collaborators

2 joint publications

Nirmish Singla

1 joint publications

Nathan Chertack

1 joint publications

Ryan C Hutchinson

1 joint publications

Xiaosong Meng